Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer

Cancer Letters

Volumn 367, Issue 2, 2015, Pages 138-146

  Zhou, Chengcheng ^a   Chen, Zhaoli ^a   Dong, Jingsi ^a   Li, Jiagen ^a   Shi, Xuejiao ^a   Sun, Nan ^a   Luo, Mei ^a   Zhou, Fang ^a   Tan, Fengwei ^a   He, Jie ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Cyfra21 1; Diagnosis; Non small cell lung cancer; Serum miRNA

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; MICRORNA; MICRORNA 194; MICRORNA 652; MICRORNA 660; UNCLASSIFIED DRUG; ANTIGEN CYFRA21.1; CYTOKERATIN 19; MIRN652 MICRORNA, HUMAN; MIRN660 MICRORNA, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG ADENOCARCINOMA; MALE; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL LUNG CARCINOMA; UPREGULATION; AGED; BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; GENETICS; IMMUNOLOGY; LUNG NEOPLASMS; MIDDLE AGED; PREDICTIVE VALUE; REAL TIME POLYMERASE CHAIN REACTION; VALIDATION STUDY;

AGED; ANTIGENS, NEOPLASM; AREA UNDER CURVE; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; HUMANS; KERATIN-19; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84939223481     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.07.015     Document Type: Article

References (35)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J. Clin 2013, 63:11-30.
2. She J., Yang P., Hong Q., Bai C. Lung cancer in China: challenges and interventions. Chest 2013, 143:1117-1126.
3. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin 2011, 61:69-90.
4. Aberle D.R., Berg C.D., Black W.C., Church T.R., Fagerstrom R.M., et al. The National Lung Screening Trial: overview and study design. Radiology 2011, 258:243-253. National Lung Screening Trial Research Team.
5. Aberle D.R., Adams A.M., Berg C.D., Black W.C., Clapp J.D., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med 2011, 365:395-409. National Lung Screening Trial Research Team.
6. McDermott A.M., Heneghan H.M., Miller N., Kerin M.J. The therapeutic potential of microRNAs: disease modulators and drug targets. Pharm. Res 2011, 28:3016-3029.
7. Nana-Sinkam S.P., Croce C.M. Non-coding RNAs in cancer initiation and progression and as novel biomarkers. Mol. Oncol 2011, 5:483-491.
8. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10513-10518.
9. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
10. Boeri M., Verri C., Conte D., Roz L., Modena P., Facchinetti F., et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3713-3718.
11. Foss K.M., Sima C., Ugolini D., Neri M., Allen K.E., Weiss G.J. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J. Thorac. Oncol 2011, 6:482-488.
12. Lin P.Y., Yu S.L., Yang P.C. MicroRNA in lung cancer. Br. J. Cancer 2010, 103:1144-1148.
13. McDonald J.S., Milosevic D., Reddi H.V., Grebe S.K., Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin. Chem 2011, 57:833-840.
14. Gillis A.J., Rijlaarsdam M.A., Eini R., Dorssers L.C., Biermann K., Murray M.J., et al. Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle. Mol. Oncol 2013, 7:1083-1092.
15. Edge S.B., Compton C.C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol 2010, 17:1471-1474.
16. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5003-5008.
17. Turchinovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011, 39:7223-7233.
18. Wang K., Zhang S., Weber J., Baxter D., Galas D.J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 2010, 38:7248-7259.
19. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol 2011, 13:423-433.
20. Ulivi P., Foschi G., Mengozzi M., Scarpi E., Silvestrini R., Amadori D., et al. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. Int. J. Mol. Sci 2013, 14:10332-10342.
21. Shen J., Todd N.W., Zhang H., Yu L., Lingxiao X., Mei Y., et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab. Invest 2011, 91:579-587.
22. Hennessey P.T., Sanford T., Choudhary A., Mydlarz W.W., Brown D., Adai A.T., et al. Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS ONE 2012, 7:e32307.
23. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
24. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
25. Wu X., Liu T., Fang O., Leach L.J., Hu X., Luo Z. miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27. Oncogene 2014, 33:1506-1514.
26. Chen X., Hu Z., Wang W., Ba Y., Ma L., Zhang C., et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int. J. Cancer 2012, 130:1620-1628.
27. Abd-El-Fattah A.A., Sadik N.A., Shaker O.G., Aboulftouh M.L. Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia. Cell Biochem. Biophys 2013, 67:875-884.
28. Zheng D., Haddadin S., Wang Y., Gu L.Q., Perry M.C., Freter C.E., et al. Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int. J. Clin. Exp. Pathol 2011, 4:575-586.
29. Zhang J., Zhao C.Y., Zhang S.H., Yu D.H., Chen Y., Liu Q.H., et al. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. Oncol. Rep 2014, 31:1157-1164.
30. Zhou J., Yu L., Gao X., Hu J., Wang J., Dai Z., et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J. Clin. Oncol 2011, 29:4781-4788.
31. Lujambio A., Lowe S.W. The microcosmos of cancer. Nature 2012, 482:347-355.
32. McDermott A.M., Miller N., Wall D., Martyn L.M., Ball G., Sweeney K.J., et al. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer. PLoS ONE 2014, 9. e87032.
33. Kanaan Z., Roberts H., Eichenberger M.R., Billeter A., Ocheretner G., Pan J., et al. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Ann. Surg 2013, 258:400-408.
34. Sukata T., Sumida K., Kushida M., Ogata K., Miyata K., Yabushita S., et al. Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. Toxicol. Lett 2011, 200:46-52.
35. Fortunato O., Boeri M., Moro M., Verri C., Mensah M., Conte D., et al. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction. Cell Death Dis 2014, 5. e1564.